Clinical Trials Browser

Not yet recruiting × Interventional × vorasidenib × Clear all

NCT07629089 2026-06-05

VALIENT

Phase 1 Not yet recruiting

Brain Neoplasms, Glioma

NCT07215910 2025-10-14

Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer

Phase 3 Not yet recruiting

Astrocytoma, Lymphoma, Follicular